SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ANTIVIRALS INC. http://www.antivirals.com
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mark Adams who wrote (148)3/9/1999 5:47:00 PM
From: DELT1970  Read Replies (1) of 167
 
I see a year of cash on hand, but most importantly, the company made a key statement in this release which I have not seen before.

The antisense treatment for restenosis, management believes, is a viable product candidate, well poised to enter the clinic by the end of this year. Data suggests to management that its antisense technology will prove to be superior to competing compounds.

Patients will soon be enrolled in the Phase III licensing trials for colorectal cancer, for which the vaccine is currently being made. Patients will also be enrolled for Phase II studies in pancreatic and prostate cancers.

And what we are really waiting for: the company is exploring a variety of opportunities including collaborations with pharmaceutical partners that will support the product developments.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News